These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 22960325
1. A comparison of the effects of digoxin, ouabain and milrinone on naloxone-precipitated withdrawal syndrome in mice. Bai YL, Chu QJ, Li J, Chen YY, Li WJ, Zhang Q. Eur J Pharmacol; 2012 Nov 05; 694(1-3):69-74. PubMed ID: 22960325 [Abstract] [Full Text] [Related]
3. Role of Na(+), K(+)-ATPase in morphine-induced antinociception. Masocha W, Horvath G, Agil A, Ocana M, Del Pozo E, Szikszay M, Baeyens JM. J Pharmacol Exp Ther; 2003 Sep 05; 306(3):1122-8. PubMed ID: 12756273 [Abstract] [Full Text] [Related]
4. Selective potentiation by ouabain of naloxone-induced withdrawal contractions of isolated guinea-pig ileum following acute exposure to morphine. Mundey MK, Mason R, Wilson VG. Br J Pharmacol; 1998 Jul 05; 124(5):911-6. PubMed ID: 9692776 [Abstract] [Full Text] [Related]
5. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice. Nemoto W, Sato T, Nakagawasai O, Yaoita F, Silberring J, Tadano T, Tan-No K. Neuropeptides; 2013 Jun 05; 47(3):187-91. PubMed ID: 23290539 [Abstract] [Full Text] [Related]
6. Effects of acute and continuous morphine administration on catecholamine-sensitive adenosine triphosphatase in mouse brain. Desaiah D, Ho IK. J Pharmacol Exp Ther; 1979 Jan 05; 208(1):80-5. PubMed ID: 215749 [Abstract] [Full Text] [Related]
7. Dopaminergic influence on withdrawal jumping behavior in morphine-dependent mice. Tseng LF, Brase DA, Loh HH. Res Commun Chem Pathol Pharmacol; 1976 Nov 05; 15(3):435-46. PubMed ID: 1033590 [Abstract] [Full Text] [Related]
8. Quantitation of physical dependence in mice by naloxone-precipitated jumping after a single dose of morphine. Smits SE. Res Commun Chem Pathol Pharmacol; 1975 Apr 05; 10(4):651-61. PubMed ID: 1171511 [Abstract] [Full Text] [Related]
9. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome. Rehni AK, Bhateja P, Singh TG, Singh N. Behav Pharmacol; 2008 May 05; 19(3):265-9. PubMed ID: 18469544 [Abstract] [Full Text] [Related]
10. Suppressive effects by cysteine protease inhibitors on naloxone-precipitated withdrawal jumping in morphine-dependent mice. Tan-No K, Sato T, Shimoda M, Nakagawasai O, Niijima F, Kawamura S, Furuta S, Sato T, Satoh S, Silberring J, Terenius L, Tadano T. Neuropeptides; 2010 Jun 05; 44(3):279-83. PubMed ID: 20189644 [Abstract] [Full Text] [Related]
11. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal. Hodgson SR, Hofford RS, Norris CJ, Eitan S. Behav Pharmacol; 2008 Dec 05; 19(8):805-11. PubMed ID: 19020415 [Abstract] [Full Text] [Related]
12. Acute effects of digoxin on plasma aldosterone and cortisol in monkeys. Kau MM, Kan SF, Wang JR, Wang PS, Lau YT, Wang SW. Metabolism; 2009 Jan 05; 58(1):55-61. PubMed ID: 19059531 [Abstract] [Full Text] [Related]
13. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice. Li T, Hou Y, Cao W, Yan CX, Chen T, Li SB. Neurosci Lett; 2010 Jan 14; 468(3):348-52. PubMed ID: 19922770 [Abstract] [Full Text] [Related]
14. Potential involvement of tyrosine phosphatase and calpain-related pathways in opioid withdrawal syndrome in mice. Rehni AK, Singh N. Behav Pharmacol; 2012 Jun 14; 23(3):302-9. PubMed ID: 22495184 [Abstract] [Full Text] [Related]
15. Role of intracellular calcium on the modulation of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes. Ohsawa M, Kamei J. Brain Res; 1999 Jan 09; 815(2):424-30. PubMed ID: 9878862 [Abstract] [Full Text] [Related]
16. Antagonism by potassium of the inhibition of (Na(+)+K+) ATPase produced by an endogenous digitalis-like compound extracted from mammalian heart. Castañeda-Hernández G, Flores-Murrieta FJ. Arch Med Res; 1992 Jan 09; 23(1):13-7. PubMed ID: 1339224 [Abstract] [Full Text] [Related]
17. Inhibitory action of morphine on adenosine triphosphatase content in the whole and individual nuclei of mouse brain during the tolerance-dependence development and its reversal by naloxone. Mohanakumar KP, Sood PP. J Hirnforsch; 1985 Jan 09; 26(6):695-708. PubMed ID: 3005393 [Abstract] [Full Text] [Related]
18. Inhibition of naloxone-precipitated withdrawal jumping by i.c.v. and i.t. administration of saline in morphine-dependent mice. Miyamoto Y, Takemori AE. Life Sci; 1993 Jan 09; 52(13):1129-34. PubMed ID: 8450707 [Abstract] [Full Text] [Related]
19. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice. Zarrindast MR, Mohajeri S. Eur J Pharmacol; 2006 Dec 15; 552(1-3):90-8. PubMed ID: 17049514 [Abstract] [Full Text] [Related]
20. The effect of pituitary adenylate cyclase-activating polypeptide on elevated plus maze behavior and hypothermia induced by morphine withdrawal. Lipták N, Dochnal R, Babits A, Csabafi K, Szakács J, Tóth G, Szabó G. Neuropeptides; 2012 Feb 15; 46(1):11-7. PubMed ID: 22226680 [Abstract] [Full Text] [Related] Page: [Next] [New Search]